董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Eric Weisblum | 男 | Director,Chairman and Chief Executive Officer and President | 56 | 52.18万美元 | 2.78 | 2026-08-14 |
| Wayne D. Linsley | 男 | Independent Director | 69 | 6.59万美元 | 0.36 | 2026-08-14 |
| Jeff Pavell | 男 | Independent Director | 59 | 4.59万美元 | 0.33 | 2026-08-14 |
| Kevin Munoz | 男 | Independent Director | 47 | 4.59万美元 | 0.36 | 2026-08-14 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Eric Weisblum | 男 | Director,Chairman and Chief Executive Officer and President | 56 | 52.18万美元 | 2.78 | 2026-08-14 |
| Daniel Ryweck | 男 | Chief Financial Officer | 61 | 10.95万美元 | 0.37 | 2026-08-14 |
董事简历
中英对照 | 中文 | 英文- Eric Weisblum
-
Eric Weisblum，于2016年加入Point Capital Inc（一种商业发展公司，主要投资于美国小型公司），作为Spherix董事会成员，目前是首席执行官兼董事会成员。他是公共和私人公司的多产投资者，并提供管理援助和指导来帮助公司执行其业务战略。他曾审查、投资，并任职众多的公共和私人公司，也监管微型和小型股市场并购战略的执行。他也曾共同创立Whalehaven公司（对冲基金，投资了超过100个上市公司）。任职Whalehaven公司之前，他曾任职M.H.Meyerson & Co. Inc.（全面服务的金融和投资银行公司，拥有个人和机构账户）。任职M.H.Meyerson期间，他曾代表众多建立基金交易股票，以及发起、结构化、处置结构化融资交易。
Eric Weisblum is the founder, President and Chief Executive Officer of the Company, and serves as Chairman of the Company's Board of Directors. Prior to founding the Company, Mr. Weisblum was a private investor, board member, and advisor to several companies. Mr. Weisblum has experience in both licensing therapeutic assets and assisting in their development. Mr. Weisblum was a registered representative with Domestic Securities, a New Jersey based broker dealer. While with Domestic Securities, Mr. Weisblum held the Series 7 — General Securities Representative, the Series 63 — Uniform Securities Agent State Law Examination, and the Series 55 — Registered Equity Trader securities registrations. From 1993 to 2002, Mr. Weisblum originated, structured, traded, and placed structured financing transactions at M.H. Meyerson & Co. Inc., a publicly traded registered investment bank. He holds a B.A. from the University of Hartford's Barney School of Business. - Eric Weisblum，于2016年加入Point Capital Inc（一种商业发展公司，主要投资于美国小型公司），作为Spherix董事会成员，目前是首席执行官兼董事会成员。他是公共和私人公司的多产投资者，并提供管理援助和指导来帮助公司执行其业务战略。他曾审查、投资，并任职众多的公共和私人公司，也监管微型和小型股市场并购战略的执行。他也曾共同创立Whalehaven公司（对冲基金，投资了超过100个上市公司）。任职Whalehaven公司之前，他曾任职M.H.Meyerson & Co. Inc.（全面服务的金融和投资银行公司，拥有个人和机构账户）。任职M.H.Meyerson期间，他曾代表众多建立基金交易股票，以及发起、结构化、处置结构化融资交易。
- Eric Weisblum is the founder, President and Chief Executive Officer of the Company, and serves as Chairman of the Company's Board of Directors. Prior to founding the Company, Mr. Weisblum was a private investor, board member, and advisor to several companies. Mr. Weisblum has experience in both licensing therapeutic assets and assisting in their development. Mr. Weisblum was a registered representative with Domestic Securities, a New Jersey based broker dealer. While with Domestic Securities, Mr. Weisblum held the Series 7 — General Securities Representative, the Series 63 — Uniform Securities Agent State Law Examination, and the Series 55 — Registered Equity Trader securities registrations. From 1993 to 2002, Mr. Weisblum originated, structured, traded, and placed structured financing transactions at M.H. Meyerson & Co. Inc., a publicly traded registered investment bank. He holds a B.A. from the University of Hartford's Barney School of Business.
- Wayne D. Linsley
-
Wayne D.Linsley，我们的独立董事提名人之一，自2014年以来担任CFO Oncall，Inc.的运营副总裁，从2011年到2014年他担任CFO Oncall，Inc.的运营总监，该公司提供财务管理和CFO服务。在担任首席财务官Oncall，Inc.之前，2010年至2011年，Linsley先生担任Flagship Advisory&Management Group，LLC（一家管理咨询公司）的管理成员。此外，自2019年以来，Linsley先生担任Executive Outsource Group，Inc.（一家提供财务报告服务的公司）的首席执行官和唯一所有者。Linsley先生还担任过其他各种职务，包括Mettel的候补渠道经理、美国Impsat的渠道销售总监、Venali，Inc.的国民账户经理以及Broadview Networks的销售总监。自2020年1月起，Linsley先生担任Silo Pharma，Inc.的董事会成员。OTCQB:筒仓。此外，自2020年4月以来，Linsley先生一直担任HothTherapeutics，Inc.（NASDAQ:HOTH）的董事会成员。Linsley先生在锡耶纳学院（Siena College）获得会计/工商管理工商管理学士学位。
Wayne D. Linsley has served as a director of the Company since January 2020. Mr. Linsley has over 40 years of experience in business management. Since April 2020, Mr. Linsley has served as a member of the board of directors of Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical stage biopharmaceutical company. Since August 2021, Mr. Linsley has served as a member of the Board of Directors of DatChat, Inc. (NASDAQ: DATS), a blockchain, cybersecurity, and social media company. From 2014 to September 2021, Mr. Linsley served as the Vice President of Operations at CFO Oncall, Inc., a company that provides financial reporting and controller services on an outsourced basis and previously, from 2012 to 2014, Mr. Linsley worked at CFO Oncall, Inc. as an independent contractor. Mr. Linsley holds a Bachelor of Science degree in Business Administration from Siena College. - Wayne D.Linsley，我们的独立董事提名人之一，自2014年以来担任CFO Oncall，Inc.的运营副总裁，从2011年到2014年他担任CFO Oncall，Inc.的运营总监，该公司提供财务管理和CFO服务。在担任首席财务官Oncall，Inc.之前，2010年至2011年，Linsley先生担任Flagship Advisory&Management Group，LLC（一家管理咨询公司）的管理成员。此外，自2019年以来，Linsley先生担任Executive Outsource Group，Inc.（一家提供财务报告服务的公司）的首席执行官和唯一所有者。Linsley先生还担任过其他各种职务，包括Mettel的候补渠道经理、美国Impsat的渠道销售总监、Venali，Inc.的国民账户经理以及Broadview Networks的销售总监。自2020年1月起，Linsley先生担任Silo Pharma，Inc.的董事会成员。OTCQB:筒仓。此外，自2020年4月以来，Linsley先生一直担任HothTherapeutics，Inc.（NASDAQ:HOTH）的董事会成员。Linsley先生在锡耶纳学院（Siena College）获得会计/工商管理工商管理学士学位。
- Wayne D. Linsley has served as a director of the Company since January 2020. Mr. Linsley has over 40 years of experience in business management. Since April 2020, Mr. Linsley has served as a member of the board of directors of Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical stage biopharmaceutical company. Since August 2021, Mr. Linsley has served as a member of the Board of Directors of DatChat, Inc. (NASDAQ: DATS), a blockchain, cybersecurity, and social media company. From 2014 to September 2021, Mr. Linsley served as the Vice President of Operations at CFO Oncall, Inc., a company that provides financial reporting and controller services on an outsourced basis and previously, from 2012 to 2014, Mr. Linsley worked at CFO Oncall, Inc. as an independent contractor. Mr. Linsley holds a Bachelor of Science degree in Business Administration from Siena College.
- Jeff Pavell
-
Jeff Pavell，自2022年12月起担任本公司董事。自2017年1月以来，帕维尔博士一直担任Englewood Health的康复医学主任，自2005年11月以来，他一直担任纽约长老会哥伦比亚大学欧文医学中心的教员。此外，自2020年12月以来，他一直在Seton Hall的Hackensack Meridian医学院担任教员。此外，自2010年以来，帕维尔博士一直担任门诊手术中心Patient Care Associates的合伙人，自2002年以来，他一直担任物理医学和康复中心的合伙人，该中心是一家为脊椎、运动和职业损伤患者提供服务的私人医疗机构。帕维尔博士是一个委员会认证的医生，专门从事物理医学和康复领域。帕维尔博士还获得了疼痛医学的认证，专门从事脊柱、运动和介入疼痛药物的最先进的非手术治疗。帕维尔博士在约翰·霍普金斯大学获得文学学士学位，在纽约整骨医学学院获得荣誉博士学位。自2021年1月起，帕维尔博士担任特殊目的收购公司FoxWayne的董事会成员、审计委员会主席和薪酬委员会成员。此外，自2022年9月以来，Pavell博士一直担任Silo Pharma, Inc.（纳斯达克：SILO）（“Silo”）的董事以及Silo的审计委员会、薪酬委员会以及提名和公司治理委员会的主席。
Jeff Pavell has served as director since September 2022. Since January 2017, Dr. Pavell has served as Chief of Rehabilitation Medicine at Englewood Health, and since November 2005, he has been on the teaching staff at New York Presbyterian Columbia University Irving Medical Center. In addition, since December 2020 he has been on the teaching staff at Hackensack Meridian School of Medicine at Seton Hall. Furthermore, since 2010, Dr. Pavell has served as a partner at Patient Care Associates, an outpatient surgical center, and since 2002, he has served as a Partner at the Physical Medicine and Rehabilitation Center, a private medical practice serving patients with spine, sports and occupational injuries. Dr. Pavell is a Board Certified physician specializing in the field of physical medicine and rehabilitation. Dr. Pavell is also certified in pain medicine and specializes in the most advanced non operative treatments for spine, sports and interventional pain medicines. Dr. Pavell received his bachelor of arts from Johns Hopkins University and his D.O. degree with honors from the New York College of Osteopathic Medicine. Since December 2022, Dr. Pavell has served as a director of Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical stage biopharmaceutical company. Dr. Pavell holds a Doctor of Medicine degree from the New York College of Osteopathic Medicine and a Bachelor of Art degree in Political Science from John Hopkins University. - Jeff Pavell，自2022年12月起担任本公司董事。自2017年1月以来，帕维尔博士一直担任Englewood Health的康复医学主任，自2005年11月以来，他一直担任纽约长老会哥伦比亚大学欧文医学中心的教员。此外，自2020年12月以来，他一直在Seton Hall的Hackensack Meridian医学院担任教员。此外，自2010年以来，帕维尔博士一直担任门诊手术中心Patient Care Associates的合伙人，自2002年以来，他一直担任物理医学和康复中心的合伙人，该中心是一家为脊椎、运动和职业损伤患者提供服务的私人医疗机构。帕维尔博士是一个委员会认证的医生，专门从事物理医学和康复领域。帕维尔博士还获得了疼痛医学的认证，专门从事脊柱、运动和介入疼痛药物的最先进的非手术治疗。帕维尔博士在约翰·霍普金斯大学获得文学学士学位，在纽约整骨医学学院获得荣誉博士学位。自2021年1月起，帕维尔博士担任特殊目的收购公司FoxWayne的董事会成员、审计委员会主席和薪酬委员会成员。此外，自2022年9月以来，Pavell博士一直担任Silo Pharma, Inc.（纳斯达克：SILO）（“Silo”）的董事以及Silo的审计委员会、薪酬委员会以及提名和公司治理委员会的主席。
- Jeff Pavell has served as director since September 2022. Since January 2017, Dr. Pavell has served as Chief of Rehabilitation Medicine at Englewood Health, and since November 2005, he has been on the teaching staff at New York Presbyterian Columbia University Irving Medical Center. In addition, since December 2020 he has been on the teaching staff at Hackensack Meridian School of Medicine at Seton Hall. Furthermore, since 2010, Dr. Pavell has served as a partner at Patient Care Associates, an outpatient surgical center, and since 2002, he has served as a Partner at the Physical Medicine and Rehabilitation Center, a private medical practice serving patients with spine, sports and occupational injuries. Dr. Pavell is a Board Certified physician specializing in the field of physical medicine and rehabilitation. Dr. Pavell is also certified in pain medicine and specializes in the most advanced non operative treatments for spine, sports and interventional pain medicines. Dr. Pavell received his bachelor of arts from Johns Hopkins University and his D.O. degree with honors from the New York College of Osteopathic Medicine. Since December 2022, Dr. Pavell has served as a director of Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical stage biopharmaceutical company. Dr. Pavell holds a Doctor of Medicine degree from the New York College of Osteopathic Medicine and a Bachelor of Art degree in Political Science from John Hopkins University.
- Kevin Munoz
-
Kevin Mu oz，自2020年10月起担任公司董事。自2021年12月以来，Mu oz博士在Passaic县技术学院教授生物医学科学和医学干预。自2008年6月以来，Mu oz博士一直担任宾夕法尼亚州物理医学和康复中心的业务主任和医疗助理，该中心是一家专门治疗运动、脊柱、骨科和神经肌肉疾病的诊断和治疗机构。Mu oz博士拥有泽维尔大学医学院的医学博士学位和密歇根大学的运动机能学理学学士学位。
Kevin Munoz has served as a director of the Company since October 2020. Since December 2021, Dr. Muoz has taught Biomedical Science and Medical Intervention at Passaic County Technical Institute. Since June 2008, Dr. Muoz has served as the Director of Operations and Medical Assistant at The Physical Medicine and Rehabilitation Center, P.A., a diagnostic and treatment facility that specializes in treating sports, spine, orthopedic and neuromuscular conditions. Dr. Muoz holds Doctor of Medicine degree from Xavier University School of Medicine and a Bachelor of Science degree in Kinesiology from the University of Michigan. - Kevin Mu oz，自2020年10月起担任公司董事。自2021年12月以来，Mu oz博士在Passaic县技术学院教授生物医学科学和医学干预。自2008年6月以来，Mu oz博士一直担任宾夕法尼亚州物理医学和康复中心的业务主任和医疗助理，该中心是一家专门治疗运动、脊柱、骨科和神经肌肉疾病的诊断和治疗机构。Mu oz博士拥有泽维尔大学医学院的医学博士学位和密歇根大学的运动机能学理学学士学位。
- Kevin Munoz has served as a director of the Company since October 2020. Since December 2021, Dr. Muoz has taught Biomedical Science and Medical Intervention at Passaic County Technical Institute. Since June 2008, Dr. Muoz has served as the Director of Operations and Medical Assistant at The Physical Medicine and Rehabilitation Center, P.A., a diagnostic and treatment facility that specializes in treating sports, spine, orthopedic and neuromuscular conditions. Dr. Muoz holds Doctor of Medicine degree from Xavier University School of Medicine and a Bachelor of Science degree in Kinesiology from the University of Michigan.
高管简历
中英对照 | 中文 | 英文- Eric Weisblum
Eric Weisblum，于2016年加入Point Capital Inc（一种商业发展公司，主要投资于美国小型公司），作为Spherix董事会成员，目前是首席执行官兼董事会成员。他是公共和私人公司的多产投资者，并提供管理援助和指导来帮助公司执行其业务战略。他曾审查、投资，并任职众多的公共和私人公司，也监管微型和小型股市场并购战略的执行。他也曾共同创立Whalehaven公司（对冲基金，投资了超过100个上市公司）。任职Whalehaven公司之前，他曾任职M.H.Meyerson & Co. Inc.（全面服务的金融和投资银行公司，拥有个人和机构账户）。任职M.H.Meyerson期间，他曾代表众多建立基金交易股票，以及发起、结构化、处置结构化融资交易。
Eric Weisblum is the founder, President and Chief Executive Officer of the Company, and serves as Chairman of the Company's Board of Directors. Prior to founding the Company, Mr. Weisblum was a private investor, board member, and advisor to several companies. Mr. Weisblum has experience in both licensing therapeutic assets and assisting in their development. Mr. Weisblum was a registered representative with Domestic Securities, a New Jersey based broker dealer. While with Domestic Securities, Mr. Weisblum held the Series 7 — General Securities Representative, the Series 63 — Uniform Securities Agent State Law Examination, and the Series 55 — Registered Equity Trader securities registrations. From 1993 to 2002, Mr. Weisblum originated, structured, traded, and placed structured financing transactions at M.H. Meyerson & Co. Inc., a publicly traded registered investment bank. He holds a B.A. from the University of Hartford's Barney School of Business.- Eric Weisblum，于2016年加入Point Capital Inc（一种商业发展公司，主要投资于美国小型公司），作为Spherix董事会成员，目前是首席执行官兼董事会成员。他是公共和私人公司的多产投资者，并提供管理援助和指导来帮助公司执行其业务战略。他曾审查、投资，并任职众多的公共和私人公司，也监管微型和小型股市场并购战略的执行。他也曾共同创立Whalehaven公司（对冲基金，投资了超过100个上市公司）。任职Whalehaven公司之前，他曾任职M.H.Meyerson & Co. Inc.（全面服务的金融和投资银行公司，拥有个人和机构账户）。任职M.H.Meyerson期间，他曾代表众多建立基金交易股票，以及发起、结构化、处置结构化融资交易。
- Eric Weisblum is the founder, President and Chief Executive Officer of the Company, and serves as Chairman of the Company's Board of Directors. Prior to founding the Company, Mr. Weisblum was a private investor, board member, and advisor to several companies. Mr. Weisblum has experience in both licensing therapeutic assets and assisting in their development. Mr. Weisblum was a registered representative with Domestic Securities, a New Jersey based broker dealer. While with Domestic Securities, Mr. Weisblum held the Series 7 — General Securities Representative, the Series 63 — Uniform Securities Agent State Law Examination, and the Series 55 — Registered Equity Trader securities registrations. From 1993 to 2002, Mr. Weisblum originated, structured, traded, and placed structured financing transactions at M.H. Meyerson & Co. Inc., a publicly traded registered investment bank. He holds a B.A. from the University of Hartford's Barney School of Business.
- Daniel Ryweck
Daniel Ryweck，自2022年9月起担任公司首席财务官。自2020年1月起，Ryweck先生担任Mill 城市投资 III有限公司（纳斯达克股票代码：MCVT）的财务总监，该公司是一家非银行贷款和专业金融公司。从。2014年6月至2019年12月，他担任Mill 城市投资 III有限公司的首席合规官。Ryweck先生拥有明尼苏达大学卡尔森管理学院会计学学士学位。
Daniel Ryweck has served as Chief Financial Officer of the Company since September 2022. Since January 2020, Mr. Ryweck has served as Controller at Mill City Ventures III Ltd. (NASDAQ: MCVT), a non bank lender and specialty finance company. From. June 2014 to December 2019, he served as Chief Compliance Officer of Mill City Ventures III Ltd. Mr. Ryweck holds a Bachelor of Science degree in Accounting from the Carlson School of Management at the University of Minnesota.- Daniel Ryweck，自2022年9月起担任公司首席财务官。自2020年1月起，Ryweck先生担任Mill 城市投资 III有限公司（纳斯达克股票代码：MCVT）的财务总监，该公司是一家非银行贷款和专业金融公司。从。2014年6月至2019年12月，他担任Mill 城市投资 III有限公司的首席合规官。Ryweck先生拥有明尼苏达大学卡尔森管理学院会计学学士学位。
- Daniel Ryweck has served as Chief Financial Officer of the Company since September 2022. Since January 2020, Mr. Ryweck has served as Controller at Mill City Ventures III Ltd. (NASDAQ: MCVT), a non bank lender and specialty finance company. From. June 2014 to December 2019, he served as Chief Compliance Officer of Mill City Ventures III Ltd. Mr. Ryweck holds a Bachelor of Science degree in Accounting from the Carlson School of Management at the University of Minnesota.